πŸ‡ΊπŸ‡Έ FDA
Patent

US 9359380

DNA-PK inhibitors

granted A61KA61K31/506A61K31/5377

Quick answer

US patent 9359380 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/506, A61K31/5377, A61K31/5386, A61P